Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Narachi Michael

SEC-identified person · CIK 1380022 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Ultragenyx Pharmaceutical Inc. RARE Director filed 2015 - 2026
Orexigen Therapeutics, Inc. OREXQ Director · President and CEO filed 2009 - 2017
Eiger Biopharmaceuticals, Inc. EIGR Director filed 2014 - 2015
Amag Pharmaceuticals, INC. AVM Director filed 2006 - 2013

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.